Superworth

Black Diamond Therapeutics market cap BDTX

Share price times shares outstanding: what the whole company sells for, since 2020.

Today, Nov 2, 2026
$100.5M
Highest close in our data
$1.5B
May 2020

Black Diamond Therapeutics is worth $100.5M at the close on Nov 2, 2026, at $1.75 a share.

That is down 55% over the last year and down 65% over five years.

Its highest close in our data was $1.5B in May 2020.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$100.5M$95.1M$175.3M−32%
2025$147.6M$78.8M$232.9M+19%
2024$123.9M$123.9M$365M−15%
2023$145.1M$49.2M$184.4M+122%
2022$65.5M$46.2M$184.8M−66%
2021$193.1M$187.7M$1.2B−83%
2020$1.2B$854.7M$1.5Bn/a

Against its peers

Companies in Healthcare nearest Black Diamond Therapeutics' size, closest first, today.

CompanyMarket cap
BDTXBlack Diamond Therapeutics$100.5M
KEQUKewaunee Scientific$96.7M
ICCCImmucell$95.9M
LFVNLifevantage$73.5M
SPROSpero Therapeutics$60.6M
APTAlpha Pro Tech$56.3M
PDEXPro DEX$184.5M
PLXProtalix BioTherapeutics$206.3M
NATRNatures Sunshine Products$211.5M
ELMDElectromed$223.9M
UTMDUtah Medical Products$224.6M
Peer median$140.6M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Black Diamond Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.